Achieving a High Performance, Diverse Accrual, Clinical Trial Program in an Academic Health System

The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques. At the nexus of these advances are clinical trials. Trials are conducted in many types of clinical settings, but academic medical centers (AMCs), with their close ties to bench research and the analytic infrastructure and expertise inherent in their organizations, are central to the process, particularly as they evolve…
By: Manatt, Phelps & Phillips, LLP
Previous Story

Recent Regulatory Actions Against Unlicensed Pharmacy Benefit Managers in West Virginia

Next Story

Crypto Asset Management: Expansion Roadmap for Managers and Investors (Part 1)